204 related articles for article (PubMed ID: 11850210)
1. Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents.
Brueggemeier RW; Richards JA; Joomprabutra S; Bhat AS; Whetstone JL
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):75-84. PubMed ID: 11850210
[TBL] [Abstract][Full Text] [Related]
2. Aromatase and cyclooxygenases: enzymes in breast cancer.
Brueggemeier RW; Richards JA; Petrel TA
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):501-7. PubMed ID: 14623550
[TBL] [Abstract][Full Text] [Related]
3. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism.
Brueggemeier RW; Gu X; Mobley JA; Joomprabutra S; Bhat AS; Whetstone JL
Ann N Y Acad Sci; 2001 Dec; 948():51-66. PubMed ID: 11795395
[TBL] [Abstract][Full Text] [Related]
4. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.
Richards JA; Petrel TA; Brueggemeier RW
J Steroid Biochem Mol Biol; 2002 Feb; 80(2):203-12. PubMed ID: 11897504
[TBL] [Abstract][Full Text] [Related]
5. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
6. Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.
Brueggemeier RW; Díaz-Cruz ES
Minerva Endocrinol; 2006 Mar; 31(1):13-26. PubMed ID: 16498361
[TBL] [Abstract][Full Text] [Related]
7. Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer.
Díaz-Cruz ES; Brueggemeier RW
Anticancer Agents Med Chem; 2006 May; 6(3):221-32. PubMed ID: 16712450
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
Ahmad I; Shagufta
Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
[TBL] [Abstract][Full Text] [Related]
9. Aromatase and prostaglandin inter-relationships in breast adipose tissue: significance for breast cancer development.
Karuppu D; Kalus A; Simpson ER; Clyne C
Breast Cancer Res Treat; 2002 Nov; 76(2):103-9. PubMed ID: 12452446
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes.
Richards JA; Brueggemeier RW
J Clin Endocrinol Metab; 2003 Jun; 88(6):2810-6. PubMed ID: 12788892
[TBL] [Abstract][Full Text] [Related]
11. Aromatase and COX in breast cancer: enzyme inhibitors and beyond.
Brueggemeier RW; Su B; Sugimoto Y; Díaz-Cruz ES; Davis DD
J Steroid Biochem Mol Biol; 2007; 106(1-5):16-23. PubMed ID: 17616393
[TBL] [Abstract][Full Text] [Related]
12. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development.
Abran D; Dumont I; Hardy P; Peri K; Li DY; Molotchnikoff S; Varma DR; Chemtob S
Circ Res; 1997 Apr; 80(4):463-72. PubMed ID: 9118476
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.
Noble LS; Takayama K; Zeitoun KM; Putman JM; Johns DA; Hinshelwood MM; Agarwal VR; Zhao Y; Carr BR; Bulun SE
J Clin Endocrinol Metab; 1997 Feb; 82(2):600-6. PubMed ID: 9024261
[TBL] [Abstract][Full Text] [Related]
14. Collagen and prostaglandin E₂ regulate aromatase expression through the PI3K/AKT/IKK and the MAP kinase pathways in adipose stromal cells.
Tan T; Wang L; Wang B
Mol Med Rep; 2015 Sep; 12(3):4766-4772. PubMed ID: 26059638
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors.
Minghetti L; Nicolini A; Polazzi E; Créminon C; Maclouf J; Levi G
Glia; 1997 Feb; 19(2):152-60. PubMed ID: 9034831
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
18. Aromatase activity and expression in breast cancer and benign breast tissue stromal cells.
Santner SJ; Pauley RJ; Tait L; Kaseta J; Santen RJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):200-8. PubMed ID: 8989259
[TBL] [Abstract][Full Text] [Related]
19. Selective regulation of aromatase expression for drug discovery.
Brueggemeier RW; Su B; Darby MV; Sugimoto Y
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):207-10. PubMed ID: 19931613
[TBL] [Abstract][Full Text] [Related]
20. Aromatase and COX-2 expression in human breast cancers.
Brodie AM; Lu Q; Long BJ; Fulton A; Chen T; Macpherson N; DeJong PC; Blankenstein MA; Nortier JW; Slee PH; van de Ven J; van Gorp JM; Elbers JR; Schipper ME; Blijham GH; Thijssen JH
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):41-7. PubMed ID: 11850206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
